Company News in the Life Science Industry

»

Reset 

Fujifilm Exhibits Its Latest Innovations In Digital Radiography At RSNA 2017

STAMFORD, Conn., Nov. 21, 2017 /PRNewswire/ -- FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging products and medical informatics solutions, will showcase its suite of digital radiography (DR) solutions... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  Fujifilm Diosynth Biotechnologies-USA | FUJIFILM Medical Systems USA, Inc.

Fujifilm Launches New Pediatric Solutions Portfolio At RSNA 2017

STAMFORD, Conn., Nov. 21, 2017 /PRNewswire/ -- FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging and medical informatics solutions, and Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  Fujifilm Diosynth Biotechnologies-USA | FUJIFILM Medical Systems USA, Inc.

Valeant Announces Closing Of Add-On Secured Notes And Credit Agreement Amendment

LAVAL, Quebec, Nov. 21, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") announced today that it has closed its previously announced offering (the "Offering") of $750,000,000 aggregate principal amount of its 5.500% senior secured... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  Valeant Pharmaceuticals International, Inc.

Medicure Reports Financial Results for Quarter Ended September 30, 2017

WINNIPEG, Nov. 21, 2017 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, today reported its results from operations for the quarter ended September 30, 2017.

Read more ››
By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  Medicure Inc.

Ambu A/S: Major Shareholder Announcement

Read more ››
By: Nasdaq / GlobenewsWire - 21 Nov 2017
Related companies:  Ambu A/S

Reporting of transactions made by persons discharging managerial responsibilities in Orphazyme A/S

Read more ››
By: Nasdaq / GlobenewsWire - 21 Nov 2017
Related companies:  Orphazyme ApS

IBA SA : DATA CONCERNING TRANSPARENCY

Read more ››
By: Nasdaq / GlobenewsWire - 21 Nov 2017
Related companies:  Ion Beam Applications

AB Science announces the publication of Preclinical data showing that masitinb is capable of counteracting resistance to oncology treatments

Read more ››
By: Nasdaq / GlobenewsWire - 21 Nov 2017
Related companies:  AB Science SA

Bavarian Nordic Announces Exercise of Clinical Option by the US Government under Contract for Freeze-dried IMVAMUNE Smallpox Vaccine

Read more ››
By: Nasdaq / GlobenewsWire - 21 Nov 2017
Related companies:  Bavarian Nordic A/S | Bavarian Nordic GmbH

HelpMeSee To Demonstrate Eye Surgical Simulator at Comprehensive Cataract Conference 2017

MUMBAI, India, Nov. 21, 2017 /PRNewswire-USNewswire/ -- The International Society of Manual Small Incision Cataract Surgeons (ISMSICS) and HelpMeSee jointly announce a series of events for the upcoming Comprehensive Cataract Conference 2017 (CCC 2017), including demonstrations of HelpMeSee's... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  HelpMeSee

Elekta Debuts Magnetic Resonance Radiation Therapy System to Enable Precision Oncology Therapy at Radiological Society of North America Annual Meeting

CHICAGO, Nov. 21, 2017 /PRNewswire/ -- Elekta (EKTA-B.ST) is introducing its magnetic resonance radiation therapy (MR/RT) technology at the Radiological Society of North America (RSNA) 103rd Annual Meeting in Chicago November 26 to December 1. Elekta's MR-linac is the first system to enable simultaneous... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  Elekta AB

AMCP Partnership Forum Identifies Key Opportunities to Improve Patient Financial Burden in Oncology and Shift to Value-Based Care Models

ALEXANDRIA, Va., Nov. 21, 2017 /PRNewswire-USNewswire/ -- Thought leaders representing managed care organizations, providers, patients, biopharmaceutical manufacturers and other stakeholders gathered recently to find solutions to the financial burden of oncology care on patients, while also improving... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017

Avelas Biosciences to Present at Piper Jaffray Healthcare Conference

SAN DIEGO, Nov. 21, 2017 /PRNewswire/ -- Avelas Biosciences, Inc., a clinical stage oncology-focused company dedicated to improving cancer patient care from diagnosis through treatment, today announced that Carmine N. Stengone, president and chief executive officer, will present at the 29(th)... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  Avelas Biosciences, Inc.

United States $6 Billion Insulin Delivery Devices Market Outlook to 2022 - Major Players are Insulet, Medtronic, Roche, Tandem Diabetes Care, Novo Nordisk, Eli Lilly, Sanofi & Owen Mumford

DUBLIN, November 21, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

Glboal Glucose Monitoring Devices Markets, 2016-2024 - Growing Popularity of Smart, Compact, Digital, Ergonomic, and Wireless Glucose Monitors Drive Healthy Market Growth

DUBLIN, November 21, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

Novus Detox Center Alerts Police and EMS to Risk of Accidental Fentanyl Overdose

NEW PORT RICHEY, Fla., Nov. 21, 2017 /PRNewswire-iReach/ -- Two law enforcement officers exhibited signs of an overdose after accidental contact with fentanyl earlier this year;(1) meanwhile, fentanyl-related deaths are skyrocketing--in a single year, synthetic opioid overdose fatalities have... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017

MiMedx to Present at the 29th Annual Piper Jaffray Healthcare Conference

MARIETTA, Ga., Nov. 21, 2017 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of healthcare,... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  MiMedx Group, Inc.

Janssen Submits Application to U.S. FDA to Expand Indication for DARZALEX® (daratumumab) Combination Therapy for Patients with Newly Diagnosed Multiple Myeloma who are Transplant Ineligible

RARITAN, N.J., Nov. 21, 2017 /PRNewswire/ -- Janssen Biotech, Inc. today announced that it has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for DARZALEX(® )(daratumumab). This application seeks to expand the current indication,... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  Janssen Biotech, Inc. | Janssen Research & Development, LLC | Janssen Research & Development, LLC

Global $12 Billion Fluid Management Systems Market 2017-2023 by Products, Application, End-users and Geography

DUBLIN, November 21, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

ITUS Will Hold Conference Call to Discuss its CAR-T Cancer Therapeutics Program

SAN JOSE, Calif., Nov. 21, 2017 /PRNewswire/ -- ITUS Corporation (NASDAQ: ITUS) reminds interested parties that it will be holding a conference call today at 2 p.m. Pacific/5 p.m. Eastern to discuss the launch of its Chimeric Antigen Receptor T-Cell (CAR-T) cancer therapeutics program.

Read more ››
By: PR Newswire Association LLC. - 21 Nov 2017
«  1  2  3  4  5  6 7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 40,000 companies